Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple vs Quadruple Therapy with Vonoprazan for H. pylori
NCT06299605Enrolling by invitation
- Sponsor
- Shandong University
- Start
- Nov 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of vonoprazan, amoxicillin and tetracycline in Helicobacter pylori infection (3 arms), sponsored by Shandong University. Primary endpoint: Eradication Rate. Started Nov 2024; status: enrolling by invitation.
02
Drugs
vonoprazanamoxicillintetracycline
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06299605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06299605.